Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Low testosterone levels may indicate worsening of disease for men with prostate cancer

05.05.2014

For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease. That's the conclusion of a new study published in BJU International. The findings may help physicians identify patients with low-risk prostate cancer who should receive aggressive anticancer treatment.

Men with prostate cancer that is not life threatening and is only slowly progressing, can often forego treatment and instead undergo active surveillance. This involves close monitoring to ensure that their disease does not become serious and jeopardize their health.

Unfortunately, doctors currently have no reliable way of predicting which men will develop evidence of worsening or more aggressive disease during active surveillance.

Ignacio San Francisco, MD, of the Pontificia Universidad Católica de Chile, and his colleagues looked to see if testosterone levels might provide any indication. After following 154 men with low-risk prostate cancer for 38 months, the investigators found that low levels of free testosterone were significantly linked with an increased risk of developing more aggressive disease.

They found no significant association with total testosterone concentrations, although there was a general trend towards increased risk with lower levels. Free testosterone comprises one to two percent of total testosterone and is considered a useful surrogate for the biologically active portion of circulating testosterone.

"These results suggest low levels of testosterone are associated with more aggressive prostate cancer. This contradicts long-held beliefs that high testosterone is risky for prostate cancer, and low testosterone is protective," said Dr. San Francisco.

The results of this study provide valuable information to clinicians and their patients concerning risk factors for prostate cancer progression in men undergoing active surveillance.

"In borderline cases, the presence of low values of free testosterone may help determine whether it is more prudent to initiate treatment rather than continue observation," said Dr. San Francisco.

Evelyn Martinez | Eurek Alert!
Further information:
http://www.wiley.com

More articles from Studies and Analyses:

nachricht Stanford study finds brain abnormalities in chronic fatigue patients
29.10.2014 | Stanford University Medical Center

nachricht Study sheds light on genetic architecture of kidney cancer
29.10.2014 | McGill University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

Registration Open Now: 18th International ESAFORM Conference on Material Forming

28.10.2014 | Event News

Comparing Apples and Oranges? A Colloquium on International Comparative Urban Research

22.10.2014 | Event News

Battery Conference April 2015 in Aachen

16.10.2014 | Event News

 
Latest News

RESCAR 2.0: Reliability and Robustness of Electronic Systems in Electrical Cars Improved

30.10.2014 | Information Technology

Siemens to modernize pickling line for ArcelorMittal Asturias in Avilés

29.10.2014 | Press release

Image From Mars-Orbiting Spectrometer Shows Comet’s Coma

29.10.2014 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>